<http://webisa.webdatacommons.org/179583936>	<http://www.w3.org/ns/prov#value>	"Number of participants in each dose group with adverse events [ Time Frame: 6h and 1 week ] [ Designated as safety issue: Yes ]Adverse events : nausea, vomiting, diarrhoea, itching, headache, drowsiness and any other symptoms for 6h immediately after dosing and again after 1 week." .
<http://webisa.webdatacommons.org/179583936>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://www.w3.org/ns/prov#Entity> .
<http://webisa.webdatacommons.org/prov/27886442>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/179583936> .
<http://webisa.webdatacommons.org/179583936>	<http://www.w3.org/ns/prov#wasQuotedFrom>	<clinicaltrials.gov> .
<http://webisa.webdatacommons.org/prov/220609893>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/179583936> .
<http://webisa.webdatacommons.org/prov/443295098>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/179583936> .
<http://webisa.webdatacommons.org/prov/343525937>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/179583936> .